Invero Pharma Submits IND Application to FDA for Xenon-Based Therapy in Traumatic Brain Injury
BUFFALO, NY, UNITED STATES, November 25, 2025 /EINPresswire.com/ -- Invero Pharma, through its affiliate Invero Health, LLC, a clinical-stage biopharmaceutical company developing neuroprotective therapies for acute brain injuries, today announced …